A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 586 participants.
Also called NCT07112339
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 586 participants
- Sponsor
- Registry
-
NCT07112339
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Canada, Germany, Italy
- Registry status
- Recruiting
Technical summary
Registry record NCT07112339. Randomized; no masking; primary purpose treatment. Start 2025-08-15 (actual); primary completion 2028-03-23 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- Insulin icodec
- Intervention (Drug)
- Basal insulin analogues
- Lead sponsor
- Novo Nordisk A/S
Record details
- Record id
cardio:ct-nct07112339- Content hash
8ea61755c9c91e002952a6b958004ec40856f27068c408b9d7e21a78fa8e7df1